Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Dermatology Reports
Erschienen in: Current Dermatology Reports 1/2012

01.03.2012 | Epidemiology (J Gelfand, Section Editor)

Epidemiology of Cosmetic Procedures: An Update for Dermatologists

verfasst von: Joseph F. Sobanko, Sotonye Imadojemu, Christopher J. Miller

Erschienen in: Current Dermatology Reports | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The relatively nascent field of cosmetic dermatology has seen a rapid rise in the number of products and procedures used to restore and enhance appearance. Millions of Americans undergo nonsurgical cosmetic procedures every year in the United States. The constant evolution of cosmetic dermatology introduces issues of safety and efficacy, as many of the innovative products and procedures have yet to endure the test of time. Practitioners who perform cosmetic procedures will benefit from recognizing the evidence to support the safety and efficacy of current trends in cosmetic dermatology. This article updates dermatologists on the epidemiology of cosmetic procedures in the United States, reviews recent research studying the motivations of the growing numbers of cosmetic patients, and briefly reviews the safety and efficacy of some of the most popular new nonsurgical cosmetic procedures.
Literatur
1.
American Society for Aesthetic Plastic Surgery Cosmetic Surgery National Data Bank Statistics 2010. Retrieved October 9, 2011, from surgery.org
2.
Sarwer DB, Crerand CE. Body dysmorphic disorder and appearance enhancing medical treatments. Body Image. 2008;5:50–8.PubMedCrossRef
3.
4.
5.
Roenigk RK. Dermatologists perform more skin surgery than any other specialist: implications for health care policy, graduate and continuing medical education. Dermatol Surg. 2008;34:293–300.PubMedCrossRef
6.
Lee EH, Nehal KS, Dusza SW, Hale EK, Levine VJ. Procedural dermatology training during dermatology residency: a survey of third-year dermatology residents. J Am Acad Dermatol. 2011;64:475–83.PubMedCrossRef
7.
Tietje L, Cresap S. Is ‘lookism’ unjust? the ethics of aesthetics and public policy implications. Journal of Libertarian Studies. 2005;19(2):31–50.
8.
Biddle JE, Hamermesh D. Beauty and the labor market. Am Econ Rev. 1994;84(5):1174–94.
9.
Sarwer DB, Magee L, Crerand CE. Cosmetic surgery and cosmetic medical treatments. In: Thompson JK, editor. Handbook of eating disorders and obesity. Hoboken: Wiley; 2003. p. 718–37.
10.
Edmonds A. The poor have the right to be beautiful: Cosmetic surgery in neoliberal Brazil. Journal of the Royal Anthropological Institute. 2007;13:363–81.CrossRef
11.
Swami V, Chamorro-Premuzic T, Bridges S, Furnham A. Acceptance of cosmetic surgery: personality and individual difference predictors. Body Image. 2009;6:7–13.PubMedCrossRef
12.
Crockett RJ, Pruzinsky T, Persing JA. The influence of plastic surgery ‘reality TV’ on cosmetic surgery patient expectations and decision making. Plast Reconstr Surg. 2007;120:316–24.PubMedCrossRef
13.
Sperry S, Thompson JK, Sarwer DB, Cash TF. Cosmetic surgery reality TV viewership: Relations with cosmetic surgery attitudes, body image, and disordered eating. Ann Plast Surg. 2009;62(1):7–11.PubMedCrossRef
14.
von Soest T, Kvalem IL, Skolleborg KC, Roald HE. Psychosocial factors predicting the motivation to undergo cosmetic surgery. Plast Reconstr Surg. 2006;111:51–62.CrossRef
15.
Brown A, Furnham A, Glanville L, Swami V. Factors that affect the likelihood of undergoing cosmetic surgery. Aesth Surg J. 2007;27:501–8.CrossRef
16.
Honigman RJ, Phillips KA, Castle DJ. A review of psychosocial outcomes for patients seeking cosmetic surgery. Plast Reconstr Surg. 2004;113:1229–37.PubMedCrossRef
17.
Cook SA, Rosser R, Salmon P. is cosmetic surgery an effective psychotherapeutic intervention? A systematic review of the evidence. J Plast Reconstr Aesth Surg. 2006;59:1133–51.CrossRef
18.
von Soest T, Kvalem IL, Roald HE, Skolleborg KC. The effects of cosmetic surgery on body image, self-esteem, and psychological problems. J Plast Reconstr Aesth Surg. 2009;62:1238–44.CrossRef
19.
Sarwer DB, Crerand CE. Body image and cosmetic medical treatments. Body Image: An International Journal of Research. 2004;1:99–111.CrossRef
20.
Conrado LA, Hounie AG, Diniz JB, et al. Body dysmorphic disorder among dermatologic patients: Prevalence and clinical features. J Am Acad Dermatol. 2010;63:235–43.PubMedCrossRef
21.
Kohn LT, Corrigan JM, Donnaldson MS. To Err is human: building a safer health system. national institute of medicine, committee on quality of health care in America. Washington: National Academy Press; 1999.
22.
• Elston DM, Taylor JS, Coldiron B, et al.: Patient safety: Patient safety and the dermatologist. J Am Acad Dermatol 2009, 61:179-190. This article addresses medico-legal issues for the dermatologist, data on patient safety in dermatology (particularly that relates to office-based surgery), and other practice-related topics pertinent to the dermatologist with the impending changes that will occur in the health care system.PubMedCrossRef
23.
Coldiron BM, Healy C, Bene NI. Office surgery incidents: what seven years of Florida data shows us. Dermatol Surg. 2008;34:285–92.PubMedCrossRef
24.
Perlis CS, Campbell RM, Perlis RH, Malik M, Dufresne RG. Incidence of and risk factors for medical malpractice lawsuits among Mohs surgeons. Dermatol Surg. 2006;32:79–83.PubMedCrossRef
25.
Ellsworth WA, Basu CB, Iverson RE. Perioperative considerations for patient safety during cosmetic surgery – preventing complications. Can J Plast Surg. 2009;17(1):9–16.PubMed
26.
• Starling J, Coldiron BM: Outcome of 6 years of protocol use for preventing wrong site office surgery. J Am Acad Dermatol 2011, 65:807-810. This article demonstrates the successful integration of a correct surgery site protocol into a daily patient care model PubMedCrossRef
27.
28.
Sobanko JF, Scheinfeld N, Kriegel DA. Liquid injectable silicone: should you implement it in your practice? Cosmetic Dermatology. 2006;19(8):5346.
29.
Wheeler CK, Said H, Prucz R, et al. Social media in plastic surgery practices: emerging trends in North America. Aesth Surg J. 2011;31(4):435–41.CrossRef
30.
• Atiyeh BS, Rubeiz MT, Hayek SN: Aesthetic/Cosmetic surgery and ethical challenges. Aesth Plast Surg 2008, 32:829-839. This article covers many of the ethical challenges that the cosmetic surgeon faces on a daily basis.CrossRef
31.
Adeoye S, Bozic K. Direct to consumer advertising in healthcare: history, benefits, and concerns. Clin Orthop. 2007;457:96–104.PubMed
32.
Berbos ZJ, Lipham WJ. Update on botulinum toxin and dermal fillers. Curr Opin Ophthalmol. 2010;21:387–95.PubMed
33.
Karsai S, Raulin C. Current evidence on the unit equivalence of different botulinum neurotoxin A formulations and recommendations for clinical practice in dermatology. Dermatol Surg. 2009;35:1–8.PubMedCrossRef
34.
• Carruthers J, Carruthers A: Botulinum toxin in facial rejuvenation: an update. Obstet Gynecol Clin N Am 2010, 37:571-582. Although published outside of the dermatologic literature, this is a concise but very informative update on the facial rejuvenating properties of BoNT CrossRef
35.
Coté TR, Mohan AK, Polder JA, et al. Botulinum toxin type A injections: adverse events reported to the US food and drug administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53:407–15.PubMedCrossRef
36.
Tremaine AM, McCullough JL. Botulinum toxin type A for the management of glabellar rhytids. Clin Cosm Invest Derm. 2010;3:15–23.
37.
Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004;17:59–67.PubMedCrossRef
38.
• Brandt F, O'Connell C, Cazzangia A, et al.: Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. Dermatol Surg 2010, 36:2111–2118. This article presents a new and interesting formulation of BoNT that could drastically change the field.PubMedCrossRef
39.
Flynn TC. Use of intraoperative botulinum toxin in facial reconstruction. Dermatol Surg. 2009;35:182–8.PubMedCrossRef
40.
Gassner HG, Brissett AE, Otley CC, et al. Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study. Mayo Clin Proc. 2006;81(8):1023–8.PubMedCrossRef
41.
Wilson AM. Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg. 2006;117:1758–66.PubMedCrossRef
42.
Venus MR. Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg. 2007;119(1):423–4. author reply 424.PubMedCrossRef
43.
44.
Christensen LH. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg. 2009;35:1612–9.PubMedCrossRef
45.
• Rohrich RJ, Pessa JE: The fat compartments of the face: Anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007,119:2219-2227. This cadaveric study has made a significant contribution to the way in which facial aging is analyzed and addressed.PubMedCrossRef
46.
• Fitzgerald R, Vkeggaar D: Facial volume restoration of the aging face with poly-l-lactic acid. Dermatol Ther 2011,24:2-27. This review elegantly describes and illustrates facial rejuvenation with PLLA and should be read by both novice and experienced injectors.PubMedCrossRef
47.
Marmur E, Green L, Buss M. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds. Dermatol Surg. 2010;36:309–15.PubMedCrossRef
48.
Brandt F, Bank D, Cross SL, et al. A lidocaine-containing formulation of large-gel particle hyaluronic acid alleviates pain. Dermatol Surg. 2010;36:1876–85.PubMedCrossRef
49.
Marmur E, Al Quaran H, De Sa Earp AP, et al. Five patient satisfaction pilot study of calcium hydroxylapatite injection for treatment of aging hands. Dermatol Surg. 2009;35:1978–84.PubMedCrossRef
50.
Palm MD, Woodhall KE, Butterwick, et al. Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients. Dermatol Surg. 2010;36:161–70.PubMedCrossRef
51.
Goldman MP. Cosmetic use of poly-l-lactic acid: My techniques for success and minimizing complications. Dermatol Surg. 2011;37:688–93.PubMedCrossRef
52.
53.
Lambros VS. Hyaluronic acid injections for correction of the tear trough deformity. Plast Reconstr Surg. 2007;120(6):74S–80S.PubMedCrossRef
54.
Narins RS. Minimizing adverse events associated with poly-L-lactic acid injection. Dermatol Surg. 2008;34:S100–4.PubMedCrossRef
55.
Beer K. A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatol Surg. 2007;33:S159–67.PubMedCrossRef
56.
Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg. 2009;35:1672–80.PubMedCrossRef
57.
Kang MS, Prak ES, Shin HS, et al. Skin necrosis of the nasal ala after injection of dermal fillers. Dermatol Surg. 2011;37:375–80.PubMedCrossRef
58.
• Narins RS, Coleman WP, Glogau RG: Recommendations and treatment options for nodules and other filler complications. Dermatol Surg 2009, 35:1667-1671. This is a thorough summary of the indications for dermal fillers and the complications and the treatment options of associated with fillers.PubMedCrossRef
59.
• Rohrich RJ, Monheit G, Nguyen AT, Fagien S: Soft-tissue filler complications: The important role of biofilms. Plast Recon Surg 2010, 125(4):1250-1256. This review article addresses soft tissue complications as a whole and focuses on the important role that biofilms have in delayed complications
60.
Monheit GD, Rohrich R. The nature of long-term fillers and the risk of complications. Dermatol Surg. 2009;35:1598–604.PubMedCrossRef
61.
Sobanko JF, Alster TS: Management of acne scarring: a comparative review of laser surgical approaches. Am J Clin Dermatol (in press)
62.
• Sobanko JF, Alster TS: Laser treatment for improvement and minimization of facial scars. Facial Plast Surg Clin N Am 2011, 19(3):527-542. A useful guide and summary of laser therapy as it relates to scar remodeling.CrossRef
63.
Chan NPY, Ho SGY, Shek SYN, et al. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med. 2010;42:712–9.PubMedCrossRef
64.
Campbell TM, Goldman MP. Adverse events of fractionated carbon dioxide laser: review of 373 treatments. Dermatol Surg. 2010;36:1645–50.PubMedCrossRef
65.
Tierney EP, Hanke CM. Recent advances in combination treatments for photoaging: review of the literature. Dermatol Surg. 2010;36:1–12.CrossRef
66.
• Brightman LA, Brauer JA, Anolik R, et al.: Ablative and fractional ablative lasers. Dermatol Clin 2009, 27:479–489. This is a very thorough summary of the history, mechanisms of action, and indications for the numerous laser modalities.PubMed
67.
Tierney E, Mahmoud BH, Srivastava D, et al. Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial. Dermatol Surg. 2009;35:1172–80.PubMedCrossRef
68.
Lin JY, Warger WC, Izikson L, et al. A prospective, randomized controlled trial on the efficacy of fractional photothermolysis on scar remodeling. Lasers Surg Med. 2011;43:265–72.PubMedCrossRef
69.
De Angelis F, Kolesnikova L, Renato F, et al. Fractional nonablative 1540-nm laser treatment of striae distensae in Fitzpatrick skin types II to IV: Clinical an histological results. Aesth Surg J. 2011;31(4):411–9.CrossRef
70.
Sherling M, Friedman PM, Adrian R, et al. Consensus recommendations on the use of an erbium-doped 1,550-nm fractionated laser and its applications in dermatologic laser surgery. Dermatol Surg. 2010;36:461–9.PubMedCrossRef
71.
Wind BS, Kroon MW, Meesters AA, et al. A. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med. 2010;42:607–12.PubMedCrossRef
72.
Kim WS, Lee HI, Lee JW, et al. Fractional photothermolysis laser treatment of male pattern hair loss. Dermatol Surg. 2011;37:41–51.PubMedCrossRef
73.
Beachofsky TM, Henning JS, Hivnor CM. Induction of de novo hair regeneration in scars after fractionated carbon dioxide laser therapy in three patients. Dermatol Surg. 2011;37:1365–8.CrossRef
74.
Greve B, Raulin C. Professional errors caused by lasers and intense pulsed light technology in dermatology and aesthetic medicine: preventative strategies and case studies. Dermatol Surg. 2002;28:156–61.PubMedCrossRef
75.
Biesman BS. Fractional ablative skin resurfacing: complications. Lasers Surg Med. 2009;41:177–8.PubMedCrossRef
76.
Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg. 2008;34:310–07.CrossRef
77.
Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg. 2010;36:299–306.PubMedCrossRef
78.
Kono T, Chan HH, Groff WF, et al. Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians. Lasers Surg Med. 2007;39:311–4.PubMedCrossRef
79.
Abbasi NR, Dover JS. Fractional laser resurfacing: why all the fuss? Dermatol Surg. 2010;36:1–2.CrossRef
80.
Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surg Med. 2009;41:179–84.PubMedCrossRef
81.
Palm MD, Guiha IC, Goldman MP. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse events. Dermatol Surg. 2010;36:1026–33.PubMedCrossRef
82.
Sadick NS. Choosing the appropriate sclerosing concentration for vessel diameter. Dermatol Surg. 2010;36:976–81.PubMedCrossRef
83.
Palm MD. Commentary: choosing the appropriate sclerosing concentration for vessel diameter. Dermatol Surg. 2010;36:982.PubMedCrossRef
84.
Stucker M, Kobus S, Altmeyer P, et al. Review of published information on foam sclerotherapy. Dermatol Surg. 2010;36:983–92.PubMedCrossRef
85.
Njisten T, van den Bos RR, Goldman MP, et al. Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol. 2009;60:110–9.CrossRef
86.
87.
• Guex J: Complications of sclerotherapy: an update. Dermatol Surg 2010, 36:1056–1063. This article is a helpful summary of the complications associated with sclerotherapy.
88.
Smith S, Faigen S, Whitcup SM, et al.: Eyelash growth in subjects treated with bimatoprost: A multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. J Am Acad Dermatol 2011 Sep [Epub, ahead of print]
89.
Priluck JC, Fu S. Latisse-induced skin hyperpigmentation. Arch Ophthalmaol. 2010;128(6):792–3.CrossRef
90.
Avram MM, Harry RS. Cryolipolysis for subcutaneous fat layer reduction. Lasers Surg Med. 2009;41:703–8.PubMedCrossRef
91.
92.
Zelickson BD, Dressel TD. Discussion of laser-assisted liposuction. Lasers Surg Med. 2009;41:709–13.PubMedCrossRef
93.
Issa MC, Maceira J, Vieira MC, et al. Photorejuvenation with topical methyl aminolaevulinate and red light: a randomized prospective clinical, histopathologic and morphometric study. Dermatol Surg. 2010;36(1):39–48.PubMedCrossRef
94.
MacGregor JL, Dover JS. The evolving role of photodynamic therapy for the treatment of photoaged skin. Dermatol Surg. 2010;36:49–51.PubMedCrossRef
95.
Sukal SA, Geronemus RG. Thermage: the nonablative radiofrequency for rejuvenation. Clin Dermatol. 2008;26:602–7.PubMedCrossRef
96.
Anolik R, Chapas AM, Brightman LA, et al. Radiofrequency devices for body shaping: A review and study of 12 patients. Semin Cutan Med Surg. 2009;28:236–43.PubMedCrossRef
97.
Brown SA, Greenbaum L, Shtukmaster S, et al. Characterization of nonthermal focused ultrasound for noninvasive selective fat cell disruption. Plast Reconstr Surg. 2009;124:92–101.PubMedCrossRef
98.
Alam M, White LE, Martin N, et al. Ultrasound tightening of facial and neck skin: A rater-blinded prospective cohort study. J Am Acad Dermatol. 2010;62:262–9.PubMedCrossRef
99.
Gadsden E, Aguilar MT, Smoller BR, et al. Evaluation of a novel high-intensity focused ultrasound device for ablating subcutaneous adipose tissue for noninvasive body contouring: Safety studies in human volunteers. Aesth Surg J. 2011;31(4):401–10.CrossRef
Metadaten
Titel
Epidemiology of Cosmetic Procedures: An Update for Dermatologists
verfasst von
Joseph F. Sobanko
Sotonye Imadojemu
Christopher J. Miller
Publikationsdatum
01.03.2012
Verlag
Current Science Inc.
Erschienen in
Current Dermatology Reports / Ausgabe 1/2012
Elektronische ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-011-0006-2

Weitere Artikel der Ausgabe 1/2012

Current Dermatology Reports 1/2012 Zur Ausgabe

Epidemiology (J Gelfand, Section Editor)

A Review of the Epidemiology of Cardiovascular Comorbidities in Psoriasis

Epidemiology (J Gelfand, Section Editor)

Impact of Long-Term Antibiotic Use for Acne on Bacterial Ecology and Health Outcomes: A Review of Observational Studies

Invited Commentary

Current Developments in Viral Skin Diseases

Epidemiology (J Gelfand, Section Editor)

Comorbidity in Atopic Dermatitis

Epidemiology (J Gelfand, Section Editor)

The Epidemiology and Prevention of Herpes Zoster

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise